DiviDrip · IDYA

IDYA — IDEAYA Biosciences, Inc.

IDYA is IDEAYA Biosciences, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $40.17. Market cap: $3.88B. Capital Quality Rank: 83/100 — Elite compounder.

Stock snapshot

Price$40.17
Market cap$3.88B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)83 / 100 · Elite compounder
ROIC (TTM)-13.8%
Revenue CAGR (3y)62.5%
Shareholder buyback yield-7.69%
Altman Z-score zoneSafe

About IDYA

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Listed2019Employees145HQSouth San Francisco, CASectorHealthcareWebsiteideayabio.com

Related non-dividend companies

Other non-dividend stocks investors research alongside IDYA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is IDYA's current stock price?

IDYA (IDEAYA Biosciences, Inc.) is currently trading at $40.17.

Does IDYA pay a dividend?

IDYA (IDEAYA Biosciences, Inc.) does not currently pay a regular dividend.

What is IDYA's Capital Quality Rank?

IDYA has a Capital Quality Rank of 83/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track IDYA in DiviDrip

Add IDYA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow